- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07392944
Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Homes (MOVE4CARE) (MOVE4CARE)
Effects of a Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Homes: MOVE4CARE
Study Overview
Status
Intervention / Treatment
Detailed Description
Individuals residing in nursing homes commonly present with physical frailty and/or cognitive impairment. These geriatric syndromes are strongly associated with accelerated functional and cognitive decline, increased dependency, elevated fall risk, higher rates of hospitalization, and increased mortality. Accordingly, long-term care settings require evidence-based interventions capable of preserving functional capacity and cognitive performance while reducing fall incidence. Non-pharmacological approaches, particularly multicomponent exercise training, have demonstrated beneficial effects on physical and cognitive outcomes in institutionalized older adults. Nevertheless, existing evidence remains limited by methodological heterogeneity, underscoring the need for confirmation through rigorously designed randomized controlled trials. Therefore, this study proposes a 12-week randomized controlled trial in older adults living in nursing homes to evaluate the efficacy of a multicomponent exercise training program incorporating resistance and power, balance, and aerobic components on physical function, cognitive performance, and fall prevention.
The primary objective is to determine whether a multicomponent exercise program produces greater improvements in physical and cognitive function and larger reductions in fall rates compared with a stretching and relaxation program used as an active control. Secondary objectives are to assess whether intervention effects are sustained six weeks following program cessation and to examine the moderating influence of specific subgroups, including frail older adults and individuals with dementia, on intervention-related outcomes.
This study will be conducted as a 12-week assessor-blinded randomized controlled trial with a six-week post-intervention follow-up in nursing homes located in Vila Nova de Gaia, Porto District, Portugal. Participants will be randomly allocated to either a multicomponent exercise training group or an active control group. The intervention group will engage in supervised multicomponent exercise training twice weekly on nonconsecutive days to mitigate fatigue and overtraining. Each session will last 50 to 60 minutes and will comprise a standardized warm-up, progressive resistance and power exercises integrated with aerobic and balance training, followed by a cool-down period consisting of stretching and flexibility exercises. The exercise protocol will be aligned with the Global Consensus on Optimal Exercise recommendations for promoting healthy longevity in older adults. The active control group will participate in stretching, relaxation, and deep-breathing exercises, as well as low-intensity seated physical activities. Outcome assessments will be conducted at baseline, post-intervention at 12 weeks, and at follow-up at 18 weeks, with fall events prospectively monitored on a weekly basis throughout the study period.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Maria Joana Carvalho, PhD
- Phone Number: +351 220425316
- Email: Jcarvalho@fade.up.pt
Study Locations
-
-
-
Porto, Portugal, 4000
- Recruiting
- Faculty of Sports, University of Porto
-
Contact:
- Joana Carvalho, PhD
- Email: Jcarvalho@fade.up.pt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Ability to ambulate (with or without assistance);
- Ability to perform chair stands (with or without assistance);
- Ability to understand and properly follow testing procedures.
Exclusion Criteria:
- Any contraindication that precludes exercise performance or testing procedures, including terminal illness, uncontrolled disease, or other unstable medical conditions;
- Short Physical Performance Battery (SPPB) score < 3 points;
- Participation in any exercise intervention within the past 3 months;
- Simultaneous participation in another clinical trial during the study;
- Planned transfer to another nursing home facility, to home, or to hospitalization during the intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Multicomponent exercise
Supervised multicomponent exercise training.
|
Twice-weekly for the 12-week duration.
The exercise intervention will take place at the nursing homes and consists of 12 weeks of supervised multicomponent exercise training, performed twice weekly on nonconsecutive days to avoid overtraining and fatigue.
Each session will last 50-60 min and consist of a warm-up, progressive resistance and power exercises combined with aerobic and balance activities, and a 5-min cool-down period (stretching and flexibility movements).
The exercise protocol will follow the Global Consensus on Optimal Exercise recommendations for enhancing healthy longevity in older adults.
|
|
Active Comparator: stretching and relaxation program
Stretches, deep breathing and relaxation exercises
|
Twice-weekly for the 12-week duration.
The active control Program consist of stretches, deep breathing and relaxation techniques, general (light intensity) physical activity in the sitting position.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline on Short Physical Performance Battery (SPBB)
Time Frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
The Short Physical Performance Battery (SPPB) is a standardized assessment tool of lower limb function, testing 3 dimensions: standing balance, walking speed, and chair stands.
Each component is scored between 0-4, total score from 0 (poor performance) to 12 (best performance).
|
Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline on Handgrip test
Time Frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
Handgrip strength will be obtained with a Digital hand dynamometer (Sammons Preston Inc., Bolingbrook, Illinois, USA).
Measurements will be carried out following the American Society of Hand Therapists recommendations, and each participant will perform three attempts with a pause of 15s between trials
|
Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
|
Falls rate
Time Frame: Weekly tracking over 18-week study period
|
The number of self-reported falls during the 12-week intervention period (i.e., rate of falls) and follow-up (without intervention).
|
Weekly tracking over 18-week study period
|
|
Change from baseline in executive functions as measured by the Trail Making Test (Part A) and Digit Substitution Symbol Test
Time Frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
The Trail Making Test Part A (TMT-A) is a widely used neuropsychological measure of visual attention, processing speed, and psychomotor function.
Participants are required to connect numbered circles in sequential order as quickly and accurately as possible.
Performance is typically scored by completion time in seconds, with longer times indicating poorer performance.
The Digit Symbol Substitution Test (DSST) is a standardized measure of processing speed, attention, working memory, and visuomotor coordination.
Participants are asked to match symbols to corresponding numbers according to a reference key within a fixed time (90 seconds).
The total number of correct substitutions constitutes the outcome measure, with higher scores reflecting better cognitive performance
|
Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
|
Change from Baseline on Timed Up and Go (TUG)
Time Frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
The Timed Up and Go (TUG) is a standardized assessment of functional mobility.
Briefly, the participants will be instructed to rise from a chair, walk 3 meters at their usual pace, turn around, walk back to the chair, and sit down.
The time taken to complete the task will be recorded and used as outcome, with longer durations representing poorer functional mobility.
|
Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
|
Change from baseline in global cognitive function as measured by the Montreal Cognitive Assessment (MoCA)
Time Frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
The Montreal Cognitive Assessment (MoCA) is a brief, standardized cognitive screening tool, that assesses multiple cognitive domains (global cognitive function), including attention, executive functions, memory, language, visuospatial abilities, abstraction, calculation, and orientation.
The test consists of a 30-point scale and typically requires approximately 10 minutes to administer.
Higher scores indicate better cognitive performance.
|
Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
|
Change from baseline in mood as measured by the Geriatric Depression Scale
Time Frame: Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
The short-version of the Geriatric Depression Scale (GDS-15) is a brief, screening instrument designed to identify depressive symptoms.
The total score ranges from 0 to 15, with higher scores indicating greater depressive symptom severity.
|
Baseline, immediately after 12 weeks of intervention and after 18 weeks follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Maria Joana Carvalho, PhD, Universidade do Porto
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Mental Disorders
- Pathologic Processes
- Neurocognitive Disorders
- Pathological Conditions, Signs and Symptoms
- Behavior
- Frailty
- Dementia
- Motor Activity
- Therapeutics
- Mind-Body Therapies
- Complementary Therapies
- Behavior Therapy
- Psychotherapy
- Behavioral Disciplines and Activities
- Relaxation Therapy
Other Study ID Numbers
- CEFADE322025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
The University of Hong KongNot yet recruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
Clinical Trials on Multicomponent exercise intervention
-
Antalya Bilim UniversityIstanbul University - CerrahpasaCompletedQuality of Life | Exercise | Well-being | Older People | Coping | Woman's HealthTurkey
-
Fundacion Miguel ServetUniversidad Pública de Navarra; Complejo Hospitalario de NavarraCompletedFrailty | Disability Physical | Hospital Acquired ConditionSpain
-
University of the Basque Country (UPV/EHU)Completed
-
Foundation University IslamabadCompletedPeripheral Diabetic NeuropathyPakistan
-
Montreal Heart InstituteCompletedNeurodegenerative Diseases | Primary Progressive Aphasia | Semantic Dementia | Logopenic Progressive Aphasia | Non-fluent AphasiaCanada
-
Federal University of PelotasRecruitingBreast Cancer FemaleBrazil
-
Complejo Hospitalario Universitario de AlbaceteRecruiting
-
National University Hospital, SingaporeNational Medical Research Council (NMRC), SingaporeUnknownFrail Elderly Syndrome
-
Federal University of Rio Grande do SulRecruiting
-
Fundacion Miguel ServetCompletedCancer | Aging | Hospital Acquired Condition | DebilitySpain